EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSOSIG00000018174
Gene Symbol: GRIA3A
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSOSIG00000012207
Gene Symbol: GRIA4B
1 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSOSIG00000021674
Gene Symbol: GRIN2BB
1 Cross references
250 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSOSIG00000010102
Gene Symbol: GRM2B
1 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSOSIG00000011657
Gene Symbol: GRM3
1 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSOSIG00000014506
Gene Symbol: GRM5B
1 Cross references
214 Possible Orthologues:

Glutaminase

Ensembl ID : ENSOSIG00000012852
Gene Symbol: GLS
1 Cross references
232 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSOSIG00000009171
Gene Symbol: GLSA
1 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSOSIG00000010961
Gene Symbol: GSK3AA
1 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSOSIG00000014929
Gene Symbol: GSK3AB
1 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSOSIG00000001192
Gene Symbol: GSK3BA
1 Cross references
222 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSOSIG00000016296
Gene Symbol: GHRHR
1 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).